Moderna says updated COVID vaccine effective against new variant

September 06, 2023 11:58 PM AEST | By Investing

Google News:

Moderna says updated COVID vaccine effective against new variant — Image source: Kalkine Media

Recent News

Banks Drive ASX 200 as Miners Retreat on Commodity Weakness

Airbus notches $21 bn in orders at Paris Air Show while Boeing keeps l...

Energy and Healthcare Stocks in Focus on the ASX 200 Amid Market Volat...

Clarity Pharmaceuticals (ASX:CU6) Advances U.S. Manufacturing in ASX 3...

Investing.com -- Moderna Inc (NASDAQ:MRNA) has announced that its updated COVID-19 vaccine generates a strong immune response against a new variant of the virus that has raised concerns over a possible spike in cases.

In a statement, the drugmaker said research it carried out into the shot showed an 8.7 increase in neutralizing antibodies in humans against the currently circulating BA.2.86 COVID variant.

The Centers for Disease Control is closely monitoring the Omicron mutation, warning that it may be more capable of causing infection in people who have had COVID-19 or previously received vaccines.

Moderna added that prior results indicate that the updated vaccine, which still needs approval from U.S. drug authorities before the fall 2023 vaccination season, has demonstrated a similarly effective response against other COVID variants.

"The emergence of BA.2.86 [...] underscores the need for vaccination with an updated COVID-19 vaccine, which can help reduce severe disease and hospitalizations caused by current circulating strains," Massachusetts-based Moderna said.

Shares in the company slipped in early U.S. trading on Wednesday.

This article first appeared in Investing.com

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.